Was As­traZeneca CEO Pas­cal So­ri­ot hap­py with his $14.8M in '18 com­pen­sa­tion? Prob­a­bly not so much

As­traZeneca CEO Pas­cal So­ri­ot made head­lines when he moaned about the poor pay he took home for 2017, forced to live on about $13 mil­lion in to­tal com­pen­sa­tion. That made him one of the worst paid — though cer­tain­ly not the worst — big phar­ma ex­ecs in the world. So he’s not like­ly to be much more ex­cit­ed by the small growth in com­pen­sa­tion he had for last year.

In a new­ly filed an­nu­al re­port, As­trazeneca re­vealed that So­ri­ot’s an­nu­al com­pen­sa­tion swelled to £11.3 mil­lion, up from £10.4 mil­lion for the year be­fore. That’s a bump of 9%. Trans­lat­ed to dol­lars, that’s $14.8 mil­lion for all of 2018, with a tiny raise in base salary (to £1.25 mil­lion) and a small­er bonus, with bet­ter long-term in­cen­tives.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER